Table 4.
Study | Patient selection: | Patient selection: | Patient selection: | Patient selection: | Index test: | Index test: | Index test: | Index test: | Index test: |
Consecutive or random sample | Avoid case-control/avoid artificially inflated base rate | Avoided inappropriate exclusions | Overall risk of bias | PHQ-9 interpreted blind to reference test | Was a threshold prespecified? | If translated, appropriate translation | If translated, psychometric properties reported | Overall risk of bias | |
Allegiant studies | |||||||||
13. Gräfe et al23 | ✓ | ✓ | ✓ | Low | ? | ✓ | ✓ | ✓ | Unclear |
16. Kroenke et al12 | ✓ | ✓ | ✓ | Low | ✓ | ✓ | N/A | N/A | Low |
22. Navinés et al28 | ✓ | ✓ | ✓ | Low | ✓ | ✓ | ✓ | ? | Unclear |
29. Thekkumpurath et al26 | × | × | ✓ | High | ✓ | ✓ | N/A | N/A | Low |
33. Williams et al49 | ✓ | ✓ | ✓ | Low | ? | ✓ | N/A | N/A | Unclear |
Non-allegiant studies | |||||||||
1. Adewuya et al55 | ✓ | ✓ | × | Unclear | ✓ | ✓ | N/A | N/A | Low |
2. Arroll et al42 | ✓ | ✓ | ✓ | Low | ✓ | ✓ | N/A | N/A | Low |
3. Azah et al62 | ✓ | × | ? | High | ✓ | ✓ | ✓ | ✓ | Low |
4. Chagas et al50 | ✓ | ✓ | ✓ | Low | ✓ | ✓ | ✓ | ✓ | Low |
6. de Lima Osorio et al60 | ✓ | × | ✓ | High | ? | × | N/A | N/A | High |
7. Elderon et al51 | ✓ | ✓ | ✓ | Low | ✓ | ✓ | N/A | N/A | Low |
8. Fann et al30 | ✓ | × | × | High | ✓ | ✓ | N/A | N/A | Low |
9. Fine et al56 | ✓ | ✓ | ✓ | Low | ? | ✓ | N/A | N/A | Unclear |
10. Gelaye et al31 | ? | × | ? | High | ✓ | × | ✓ | ? | High |
11. Gilbody et al57 | ? | ✓ | ? | Unclear | ✓ | ✓ | N/A | N/A | Low |
12. Gjerdingen et al48 | ✓ | ✓ | ✓ | Low | ? | ✓ | N/A | N/A | Unclear |
14. Hyphantis et al32 | ✓ | × | ✓ | High | ✓ | ✓ | ? | ? | Unclear |
15. Khamseh et al34 | ✓ | ✓ | ? | Unclear | ✓ | ✓ | ✓ | ? | Unclear |
19. Liu et al63 | ✓ | ✓ | ? | Unclear | ✓ | × | ✓ | ? | High |
20. Lotrakul et al46 | × | ✓ | ? | Unclear | ✓ | ✓ | ✓ | ? | Unclear |
23. Patel et al61 | ✓ | ✓ | ✓ | Low | ✓ | ✓ | ? | ? | Unclear |
24. Phelan et al58 | × | ✓ | ✓ | High | ✓ | × | N/A | N/A | High |
25. Rooney et al52 | ✓ | ✓ | ✓ | Low | ? | × | N/A | N/A | High |
26. Sherina et al | ✓ | ✓ | × | High | ✓ | ✓ | ✓ | ✓ | Low |
27. Sidebottom et al59 | ✓ | ✓ | ✓ | Low | ✓ | ✓ | N/A | N/A | Low |
28. Stafford et al37 | ✓ | ✓ | ✓ | Low | ✓ | ✓ | N/A | N/A | Low |
30. Thombs et al38 | × | ✓ | ? | High | ✓ | ? | N/A | N/A | Unclear |
32. Watnick et al53 | ? | × | ✓ | High | ✓ | ✓ | N/A | N/A | Low |
34. Wittkampf et al64 | ✓ | ✓ | ✓ | Low | ✓ | ? | N/A | N/A | Unclear |
35. Zhang et al54 | ✓ | ✓ | ? | Unclear | ? | ✓ | ? | ? | Unclear |
36. Zuithoff et al47 | ✓ | ✓ | ✓ | Low | ✓ | ✓ | ✓ | ? | Unclear |
Study | Reference test: | Reference test: | Reference test: | Reference test: | Reference test: | Flow / timing: | Flow / timing: | Flow / timing: | Flow / timing: |
Reference test correctly classifies target condition | Reference test interpreted blind to PHQ-9 | If translated, appropriate translation | If translated, psychometric properties reported | Overall risk of bias | Interval of 2 weeks or less | All participants receive same reference test | All participants included in analysis? | Overall risk of bias | |
Allegiant studies | |||||||||
13. Gräfe et al23 | ✓ | ? | N/A | N/A | Unclear | ✓ | ✓ | ✓ | Low |
16. Kroenke et al12 | ✓ | ✓ | N/A | N/A | Low | ✓ | ✓ | ✓ | Low |
22. Navinés et al28 | ✓ | ✓ | ? | ? | Unclear | ✓ | ✓ | ✓ | Low |
29. Thekkumpurath et al26 | ✓ | ✓ | N/A | N/A | Low | ? | ✓ | ✓ | Unclear |
33. Williams et al49 | ✓ | ? | N/A | N/A | Unclear | ? | ✓ | ✓ | Unclear |
Non-allegiant studies | |||||||||
1. Adewuya et al55 | ✓ | ✓ | N/A | N/A | Low | ✓ | ✓ | ✓ | Low |
2. Arroll et al42 | ✓ | ✓ | N/A | N/A | Low | ? | ✓ | ✓ | Unclear |
3. Azah et al62 | ✓ | ✓ | ✓ | ✓ | Low | ✓ | ✓ | × | High |
4. Chagas et al50 | ✓ | ✓ | ? | ? | Unclear | ✓ | ✓ | × | High |
6. de Lima Osorio et al60 | ✓ | ? | N/A | N/A | Unclear | ? | ✓ | ✓ | Unclear |
7. Elderon et al51 | ✓ | ✓ | N/A | N/A | Low | ✓ | ✓ | ✓ | Low |
8. Fann et al30 | ✓ | ? | N/A | N/A | Unclear | ✓ | ✓ | × | High |
9. Fine et al56 | ✓ | ? | N/A | N/A | Unclear | ? | ✓ | ✓ | Unclear |
10. Gelaye et al31 | ✓ | ✓ | ✓ | ✓ | Low | ✓ | ✓ | × | High |
11. Gilbody et al57 | ✓ | ✓ | N/A | N/A | Low | ? | ✓ | ✓ | Unclear |
12. Gjerdingen et al48 | ✓ | ? | N/A | N/A | Unclear | ✓ | ✓ | × | High |
14. Hyphantis et al32 | ✓ | ✓ | ? | ? | Unclear | ✓ | ✓ | × | High |
15. Khamseh et al34 | ✓ | ✓ | ✓ | ? | Unclear | ✓ | ✓ | ? | Unclear |
19. Liu et al63 | ✓ | ✓ | ✓ | ✓ | Low | ✓ | ✓ | ? | Unclear |
20. Lotrakul et al46 | ✓ | ✓ | ✓ | ✓ | Low | ? | ✓ | × | High |
23. Patel et al61 | ✓ | ✓ | ✓ | ? | Unclear | ? | ✓ | × | High |
24. Phelan et al58 | ✓ | ✓ | N/A | N/A | Low | ✓ | ✓ | ✓ | Low |
25. Rooney et al52 | ✓ | ? | N/A | N/A | Unclear | ? | ✓ | × | High |
26. Sherina et al | ✓ | ✓ | ✓ | ✓ | Low | ✓ | ✓ | ✓ | Low |
27. Sidebottom et al59 | ✓ | ✓ | N/A | N/A | Low | ✓ | ✓ | × | High |
28. Stafford et al37 | ✓ | ✓ | N/A | N/A | Low | ✓ | ✓ | × | High |
30. Thombs et al38 | ? | ✓ | N/A | N/A | Unclear | ✓ | ✓ | ✓ | Low |
32. Watnick et al53 | ✓ | ✓ | N/A | N/A | Low | ✓ | ✓ | ✓ | Low |
34. Wittkampf et al64 | ✓ | ✓ | N/A | N/A | Low | ? | ✓ | × | High |
35. Zhang et al54 | ✓ | ? | ✓ | ✓ | Unclear | × | ✓ | × | High |
36. Zuithoff et al47 | ✓ | ✓ | ? | ? | Unclear | ? | ✓ | ✓ | Unclear |
N/A, not applicable; PHQ-9, Patient Health Questionnaire-9.✓,criterion met; ✗, criterion not met; ?, insufficient information to code whether criterion met.